Cargando…
Recent Findings on Thymoquinone and Its Applications as a Nanocarrier for the Treatment of Cancer and Rheumatoid Arthritis
Cancer causes a considerable amount of mortality in the world, while arthritis is an immunological dysregulation with multifactorial pathogenesis including genetic and environmental defects. Both conditions have inflammation as a part of their pathogenesis. Resistance to anticancer and disease-modif...
Autores principales: | Pal, Ravi Raj, Rajpal, Vasundhara, Singh, Priya, Saraf, Shubhini A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224699/ https://www.ncbi.nlm.nih.gov/pubmed/34067322 http://dx.doi.org/10.3390/pharmaceutics13060775 |
Ejemplares similares
-
Inhalable hybrid nanocarriers for respiratory disorders
por: Maurya, Priyanka, et al.
Publicado: (2020) -
Credible Protein Targets and Curative Strategies for COVID-19: a Review
por: Singh, Priya, et al.
Publicado: (2020) -
Non-Lamellar Liquid Crystalline Nanocarriers for Thymoquinone Encapsulation
por: Yaghmur, Anan, et al.
Publicado: (2019) -
The monocyte-to-osteoclast transition in rheumatoid arthritis: Recent findings
por: Iwamoto, Naoki, et al.
Publicado: (2022) -
Recent Developments of Liposomes as Nanocarriers for Theranostic Applications
por: Xing, Hang, et al.
Publicado: (2016)